Tirzepatide is a groundbreaking dual incretin peptide that targets both GIP and GLP-1 receptors to enhance insulin secretion, suppress glucagon, and improve glucose metabolism. This innov...
Tirzepatide, a dual GIP and GLP-1 receptor agonist, offers significant, dose-dependent weight loss and metabolic benefits. Recent clinical trials demonstrate its superiority over traditio...